These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23127604)

  • 1. Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome.
    Rellini AH; Stratton N; Tonani S; Santamaria V; Brambilla E; Nappi RE
    Horm Behav; 2013 Jan; 63(1):65-71. PubMed ID: 23127604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.
    Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF
    Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen replacement for women.
    Basson R
    Can Fam Physician; 1999 Sep; 45():2100-7. PubMed ID: 10509222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinemia does not influence androgens/estrogens ratio in patients with polycystic ovarian syndrome.
    Panidis DK; Rousso DH; Matalliotakis IM; Kourtis AI; Vlassis GD; Koumantakis EE
    Int J Fertil Womens Med; 1999; 44(6):301-6. PubMed ID: 10617252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
    Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
    Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
    Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E
    Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgenic hormones and aging--the link with female sexual function.
    Davison SL; Davis SR
    Horm Behav; 2011 May; 59(5):745-53. PubMed ID: 21215268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
    Van Nieuwerburgh F; Stoop D; Cabri P; Dhont M; Deforce D; De Sutter P
    Gynecol Endocrinol; 2008 Dec; 24(12):669-73. PubMed ID: 19172534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.
    Jedel E; Gustafson D; Waern M; Sverrisdottir YB; Landén M; Janson PO; Labrie F; Ohlsson C; Stener-Victorin E
    Psychoneuroendocrinology; 2011 Nov; 36(10):1470-9. PubMed ID: 21549510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do women with polycystic ovary syndrome (PCOS) report differences in sex-typed behavior as children and adolescents?: Results of a pilot study.
    Manlove HA; Guillermo C; Gray PB
    Ann Hum Biol; 2008; 35(6):584-95. PubMed ID: 18720090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI.
    Akbarzadeh S; Ghasemi S; Kalantarhormozi M; Nabipour I; Abbasi F; Aminfar A; Jaffari SM; Motamed N; Movahed A; Mirzaei M; Rahbar AR
    Gynecol Endocrinol; 2012 Jul; 28(7):521-4. PubMed ID: 22309615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
    Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome.
    Köşüş N; Köşüş A; Kamalak Z; Hızlı D; Turhan NÖ
    Gynecol Endocrinol; 2012 Aug; 28(8):611-4. PubMed ID: 22296561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
    Jedel E; Labrie F; Odén A; Holm G; Nilsson L; Janson PO; Lind AK; Ohlsson C; Stener-Victorin E
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and polycystic ovary syndrome.
    Nisenblat V; Norman RJ
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.